| Barth, Wolfgang (Avontec 200402– joined from Bayer Pharmaceuticals) |
n. a. |
Avontec GmbH |
Germany |
| Barthel, Wolfgang (Sigma-Aldrich Chemie GmbH 200803 Country Sales Manager Germany + Austria) |
Sales Manager / Marketing Manager |
Merck (DE) (Group) |
Germany |
| Bartholomay, Gesa (Tosoh 201204 Tosoh Bioscience GmbH Marketing Projects Specialist Separations Business Unit) |
Sales Manager / Marketing Manager |
Tosoh (Group) |
Germany |
| Bartley, Mike (Protaffin 201109– Chief Development Officer before Pfizer Inc in UK) |
Clinical Research Manager |
Protaffin Biotechnologie AG |
Austria |
| Barton, Claire (T3 Pharmaceuticals 201909– CMO before Roche + Lilly + GW) |
Chief Medical Officer (CMO) |
Boehringer Ingelheim (Group) |
Switzerland |
| Barttelot, Charlotte (MMC Ventures 202203 Investor) |
Investment Manager |
Sano Genetics Ltd. |
United Kingdom (GB) |
| Barzi, Roberto (VitaTech SA 201902 Director) |
Investment Manager |
VitaTech S.A. (Zambon Family + other European high-net-worth private investors) |
|
| Basiji, David A. (Amnis Corp 201108 CEO + co-founder) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
United States (USA) |
| Basquin, Jérôme (Max Planck 201512 MPI for Biochemistry Martinsried) |
Researcher (university / research institute) |
Max Planck Society for the Advancement of Science |
Germany |
| Basteleurs, Inge (Biocartis 201301– General Counsel before UCB NV + Bayer BioScience NV) |
General Counsel / Chief Legal Officer (CLO) |
Biocartis (Group) |
Belgium |
| Bastian, Helge (Thermo Fisher 201406 General Manager Synthetic Biology before Indivumed + Sigma-Aldrich + SGS + Qiagen) |
Managing Director |
Thermo Fisher (Group) |
United States (USA) |
| Bastianelli, Giacomo (Meiogenix 201604 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Meiogenix SAS |
France |
| Bataller, Juan (Zeltia 201303 General Manager of Genomica AB) |
General Manager (management) |
PharmaMar (Group) |
Sweden |
| Bates, Elena (Optimum Strategic Communications 202304) |
Public Relations Manager / Investor Relations Manager |
Optimum Strategic Communications |
United Kingdom (GB) |
| Bates, Gordon (Lonza 201610 SVP Business Unit Head Chemical + Microbial Manufacturing) |
President/Director/Head Business Group/Unit/Division |
Lonza (Group) |
Switzerland |
| Bates, Kathy L. (Mayo Clinic 201912 Senior Director Lab Services + Partnership Developm + Numares Supersvisory Board) |
President/Director/Head of Research Organisation/Unit |
Mayo Clinic |
United States (USA) |
| Batra, Udit (Waters 202009– CEO before Merck Life Sciences + Merck Millipore + Novartis + JnJ + McKinsey) |
Chief Executive Officer (CEO) |
Waters (Group) |
United States (USA) |
| Battermann, Gerd (Merck KGaA 200803) |
n. a. |
Merck (DE) (Group) |
Germany |
| Batur, Gökhan (Polyphor 202001– promoted to CEO joined 201906 as CCO before Merck (US)) |
Chief Executive Officer (CEO) |
Spexis (Group) |
Switzerland |
| Batzl-Hartmann, Christine (Pharmacelsus 201110 Managing Director (CEO) + Founder before Novartis) |
Managing Director |
Pharmacelsus GmbH |
Germany |
| Bauer, Ariel (SGS 202401 Group VP Investor Relations, Communications + Sustainability) |
Public Relations Manager / Investor Relations Manager |
SGS (Group) |
Switzerland |
| Bauer, Christian (CCS Cell Culture Service –200712 Head Molecular Biology left CCS 12/07) |
n. a. |
Evotec (Group) |
Germany |
| Bauer, Erwin P. (BB Medtech 2003–200704 Verwaltungsrat) |
n. a. |
Bellevue (Group) |
Switzerland |
| Bauer, Eva (MC Services 201811) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Bauer, Georg (Sony 201310 Head of Engineering at Sony DADC BioSciences) |
Technical Manager |
Stratec (Group) |
Austria |
| Bauer, Günter J. (Transimmune 201205– CEO before Scienion 200901–201202 CBO + PerkinElmer Germany + Evotec + BASF) |
Chief Executive Officer (CEO) |
Transimmune AG |
Germany |
| Bauer, Johannes (TRI Thinking Research Instruments 202205 Managing Partner) |
Managing Partner |
TRI Thinking Research Instruments GmbH |
Germany |
| Bauer, Jürgen (EMBL 201105– Deputy Managing Director at EMBLEM before Gentana + Axaron Bioscience + Lesaffre) |
Managing Director |
EMBL (European Molecular Biology Laboratory) |
Germany |
| Bauer, Manuel (Ernst & Young 202206 Associate Director/Senior Industry Specialist at Global Life Sciences Center) |
Consultant (economic/technology) |
Cap Gemini Ernst & Young (Group) |
Germany |
| Bauer, Michael (EQT 202206 Partner + Global Co-Head of Healthcare Team) |
Partner (venture partner) |
EQT (Wallenberg family) (Group) |
Sweden |
| Bauer, Michael (Quantro Therapeutics 202305– CEO before Cellestia Biotech CEO) |
Chief Executive Officer (CEO) |
Quantro Therapeutics GmbH |
Austria |
| Bauer, Peter (Centogene 201601– COO before Univ Hospital Tübingen Professor) |
Chief Operating Officer (COO) |
Centogene (Group) |
Germany |
| Bauer, Reinhard (Daiichi Sankyo Europe 200803 CEO) |
Chief Executive Officer (CEO) |
Daiichi Sankyo (Group) |
Germany |
| Bauer, Sylvia |
n. a. |
Greiner (Group) |
Germany |
| Baule, Rainer (Fresenius 201004 Board Member) |
Board member |
Fresenius (Group) |
Germany |
| Bauler, James (Flag Therapeutics 201901 Director Corporate Development) |
Business Development Manager / Strategy Manager |
Flag Therapeutics (US) |
United States (USA) |
| Baum, Christopher (Humboldt Univ Berlin 202406 Board Chair at BIH) |
Board member |
Humboldt University Berlin |
Germany |
| Baumann (Buttkereit), Monika (Biotest 201308 Head of Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Grifols (Group) |
Germany |
| Baumann, Matthias (Mologen 201705– CMO before Noxxon + Focus Clinical Drug Development + Roche + BM) |
Chief Medical Officer (CMO) |
Mologen (Group) |
Germany |
| Baumann, Oliver R. (Xlife Sciences 202103 CEO) |
Chief Executive Officer (CEO) |
Xlife Sciences AG (SIX: XLS) |
Switzerland |
| Baumann, Teresa (GoSilico 202106 Co-Founder) |
Company Founder |
GoSilico GmbH |
Germany |
| Baumann, Urs (Bellevue Group 201409 CEO) |
Chief Executive Officer (CEO) |
Bellevue (Group) |
Switzerland |
| Baumann, Werner (Bayer 201605– CEO before Chief Strategy + Portfolio Officer + CFO joined Bayer1988) |
Chief Executive Officer (CEO) |
Bayer (Group) |
Germany |
| Baumeister, Hans (FyoniBio 202204 Managing Director before Glycotope 200706– Managing Director COO before BusDev) |
Managing Director |
Canton Biologics (Group) |
Germany |
| Baumert, Thomas F. (Univ Stasbourg 201904 Professor + Scientific Founder of Alentis Therapeutics) |
Professor |
University of Strasbourg |
France |
| Baumgardt, Jens (Durakult 201107 Managing Director) |
Managing Director |
Durakult GmbH |
Germany |
| Baumgart, Holger (Ernst & Young 201603 Partner + Tax Adviser at Ernst & Young GmbH Mannheim) |
n. a. |
Ernst & Young (Group) |
Germany |
| Baumgartner, Roland (4SC 201610– promoted CSO joined 2002) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
4SC (Group) |
Germany |
| Baumgartner, Tina (Accella Group 200806– Principal before Guava Technologies + SurroMed + GeneTrace Systems) |
Consultant (economic/technology) |
Accella Group |
United States (USA) |
| Baumhauer, Jon (Merck (DE) –201401 Chairman of Family + Executive Board of E Merck RETIRED 1/14) |
Supervisory Board |
Merck (DE) (Group) |
Germany |
| Baumstümmler, Bernd (Instillo Group 201507 CEO + MJR PharmJet 201101 Managing Director) |
Managing Director |
MJR PharmJet GmbH |
Germany |
| Baur, Andreas (BioLAGO eV 201710 Managing Director) |
Cluster Manager |
BioLAGO e. V. |
Germany |
| Baur, Franz (OncoLead 201012 Managing Director) |
Managing Director |
OncoLead (Group) |
Germany |
| Bausch, Alexander (Kinarus 202208 CEO and Strekin 201705 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Strekin AG |
Switzerland |
| Bausch, Ursula (Baccinex 202411 CEO + Founder) |
Chief Executive Officer (CEO) |
Adragos Pharma (Group) |
Switzerland |
| Bavaj, Paolo (Henkel 201806 Head of Corporate Venturing at Adhesive Technologies business unit) |
Business Development Manager / Strategy Manager |
Henkel (Group) |
Germany |
| Baxter, Anthony (Cyprotex 201008 CEO before deltaDOT CEO + Argenta founding CEO) |
Chief Executive Officer (CEO) |
Evotec (Group) |
United Kingdom (GB) |
| Bayerl, Thomas |
n. a. |
University of Würzburg |
Germany |
| Baynes, Roy (Eikon Therapeutics 202401 EVP + CMO before Merck Research Laboratories + Gilead + Amgen) |
Research & Development Manager |
Eikon Therapeutics (US) |
United States (USA) |
| Bazantay, Christian (Servier 201110 Managing Director of Servier Deutschland GmbH) |
Managing Director |
Servier (Group) |
Germany |
| Bazemore, Robert (Epizyme 201811 CEO) |
Chief Executive Officer (CEO) |
Epizyme Inc. (Nasdaq: EPZM) |
United States (USA) |
| Beator, Jens (SensID 202303 Business Development formerly Stratec Molecular + Protagen + Whatman S&S) |
Managing Director |
SensID GmbH |
Germany |
| Beattie, Greg (Charles River 201803 Corp VP Global Biologics Testing Solutions) |
President/Director/Head Business Group/Unit/Division |
Charles River (Group) |
United States (USA) |
| Beatty, Brad (BioProcess360 Partners 202406– Founding Partner) |
Managing Partner (investment firm) |
BioProcess360 Partners (US) |
United States (USA) |
| Beaumont, James (Metrion Biosciences 201705– Head Business Development before Evotec + Aptuit) |
Business Development Manager / Strategy Manager |
Metrion Biosciences Ltd. |
United Kingdom (GB) |
| Bech Jensen, Ejner (Agrobiomics 202309 CEO before Novozymes 201112 VP RnD) |
Chief Executive Officer (CEO) |
Agrobiomics (DK) |
Denmark |
| Bechthold, Erika (UpNano 202204–1st US Employee before Harvard Office for Technology Development) |
n. a. |
UpNano GmbH |
United States (USA) |
| Beck, Jan-Philipp (EU (govt) 202111 CEO of EIT Health) |
Chief Executive Officer (CEO) |
EU (govt) |
Germany |
| Beck, Jürgen (Memo Therapeutics 202306 CMO before prosion + Paion + Intermune + Epigenomics + Synthélabo) |
Chief Medical Officer (CMO) |
Memo Therapeutics AG (MTx) |
Switzerland |
| Beck, Matthew L. S. (Matt) (Hookipa 202210 Investor Relations before CureVac + Solebury Trout) |
Public Relations Manager / Investor Relations Manager |
Hookipa (Group) |
United States (USA) |
| Beck, Peter (Hölle & Hüttner 200807 Managing Director) |
Managing Director |
HB Technologies (Group) |
Germany |
| Beck, Thomas R. (Tom) (Fidelity Biosciences 201406 Executive Partner before Dyax + UCB Pharma) |
Partner (venture partner) |
F-Prime (Group) |
United States (USA) |
| Becker, Bernard (InterMed Discovery 200810 Managing Director) |
Managing Director |
InterMed Discovery GmbH (IMD) |
Germany |
| Becker, Chris (Protein Metrics 201209 CEO) |
Chief Executive Officer (CEO) |
Insightful Science (Group) |
United States (USA) |
| Becker, Frank (Intana Bioscience 200907 Managing Director + Founder) |
Managing Director |
Intana Bioscience GmbH |
Germany |
| Becker, Marc (CRISPR Therapeutics 201603– CFO before rEVO Biologics + Genzyme) |
Chief Financial Officer (CFO) |
CRISPR Therapeutics (Group) |
Switzerland |
| Becker, Mario (Sartorius 202308 Head of Product Group Bioreactor Technologies) |
Product Manager (personnel) |
Sartorius (Group) |
Germany |
| Becker, Sabine (Helmholtz 200912– Head BrainMet Competence Centre) |
Research & Development Manager |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Becker, Thomas |
n. a. |
Eurofins (Group) |
Germany |
| Beckerling, Andree (Accovion 201504 Managing Director (CEO)) |
Managing Director |
Clinipace (Group) |
Germany |
| Beckman, Evan (Novartis 201803 Head of Translational Medicine at Novartis Institutes for BioMedical Research) |
Research & Development Manager |
Novartis (Group) |
Switzerland |
| Beckman, Peter (Kiel (govt) 201204 Managing Director of KiWi GmbH + KiWi Tower GmbH) |
Managing Director |
|
Germany |
| Beckmann, Kai (Merck KGaA 201709– Executive Board Member for Performance Materisl before Human Resources) |
Board member, executive |
Merck (DE) (Group) |
Germany |
| Beckmann, Roland (Dutalys GmbH 201412 CSO + Co-founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Roche (Group) |
Austria |
| Bednarczuk, Piotr (Merck KGaA 201110– Head Corporate Human Resources) |
Human Resources Manager |
Merck (DE) (Group) |
Germany |
| Bedoret, Denis (Imcyse 202009– CEO before MaSTherCell + Quality Assistance SA + McKinsey & Co) |
Chief Executive Officer (CEO) |
Imcyse S.A. |
Belgium |
| Béduer, Amélie (Volumina Medical 202403 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Volumina Medical S.A. |
Switzerland |
| Beecher, Chris (IROA Technologies 201309 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
IROA Technologies LLC |
United States (USA) |
| Beeler, Kristina (Biognosys 202105– CBO before Head of Business Development joined 2017 before Nextech Invest) |
Chief Business Officer (CBO) |
Bruker (Group) |
Switzerland |
| Beer, Nicola (EU (govt) VP of EIB) |
President/Director/Head Business Group/Unit/Division |
EU (govt) |
Luxembourg |
| Beerhalter, Stefan B. (Germany (govt) 201802– VP Germany at GALS before Cardionovum GmbH + OrbusNeich Medical) |
Business Development Manager / Strategy Manager |
Germany (govt) |
Germany |
| Beery, Matan (Akvolution GmbH 201310– Managing Director) |
Managing Director |
Akvolution GmbH (Akvola Technologies) |
Germany |
| Beguir, Karim (InstaDeep 202011 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
BioNTech (Group) |
United Kingdom (GB) |
| Behar, Greg (Recipharm 202401– CEO before CEO of Nestlé Health Science before Novartis + Boehringer Ingelheim) |
Chief Executive Officer (CEO) |
Recipharm (Group) |
Sweden |
| Behbahani, Ali (New Enterprise Associates 201504) |
Investment Manager |
New Enterprise Associates (NEA) |
United States (USA) |
| Beher, Dirk (FundaMental Pharma 202404– CEO before Asceneuron + MSD UK + Amgen + Merck Serono) |
Chief Executive Officer (CEO) |
FundaMental Pharma GmbH (FMP) |
Germany |
| Behn, Herr (Intavis 200809) |
Sales Manager / Marketing Manager |
HB Technologies (Group) |
Germany |
| Behnke, Detlev (ProThera=Wacker Biotech 200501 Managing Director) |
Managing Director |
Wacker (Group) |
Germany |
| Behr, Pascal (Cytosurge 201806 CEO) |
Chief Executive Officer (CEO) |
Cytosurge AG |
Switzerland |
| Behrenbruch, Christian (Telix 201511– CEO before ImaginAb CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Telix Pharmaceuticals Ltd. (ASX: TLX) |
Australia |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 4 5 6 ... 93 94 95 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
